Journal article
Recent advances in immunotherapy of B-CLL using ex vivo modified dendritic cells
Abstract
Chronic lymphocytic leukemia (CLL) results from the relentless accumulation of small mature, slowly dividing, monoclonal B-lymphocytes. The clinical course is heterogeneous, some patients with aggressive form of the disease progressing rapidly with early death while others exhibit a more stable, possibly, non-progressing indolent type of the disease lasting many years. Despite progress in modern treatment modalities, relapse invariably occurs …
Authors
Suresh K; Rodriguez-Lecompte JC; Gauldie J; Foley R
Journal
Hematology, Vol. 10, No. 3, pp. 189–203
Publisher
Taylor & Francis
Publication Date
June 2005
DOI
10.1080/10245330500094870
ISSN
1024-5332